Prestige Biologics Co., Ltd. · 주식등의대량보유상황보고서(일반)
Report on large shareholdings (general)
6.1
프레스티지바이오로직스(주)
0000
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-11-04 |
| To: Korea Exchange | Report reference date: | 2026-11-09 |
| Reporting person: | 프레스티지바이오파마 |
| Summary |
| Issuer name | 프레스티지바이오로직스(주) | Relationship to Issuer | Largest Shareholder |
| Report Type | Change |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | 46,936,099 | 60.37 |
| Current Report | 46,901,699 | 60.32 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | 특별관계자 보유주식 변동 |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | 프레스티지바이오로직스(주) | Company code | 334970 |
| Entity type | KOSDAQ-Listed Company | Total Issued Voting Shares (shares) | 77,752,637 |
발행회사의 의결권있는 발행주식 총수는 당사의 유상증자대금 납입 완료에 따라 증가된 주식총수를 반영한 수치입니다.
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | Change | Joint signatories |
| Reporting person type | Foreign Corporation | Nationality | Singapore |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | 프레스티지바이오파마 | Chinese characters (English) | Prestige Biopharma Limited |
| Address (Head Office) [Town/District Level Only] | #04-24 Nucleos South Building,Singapore 138567 | Date of Birth or Business Registration No., etc. | 49190 |
| Occupation (business) | 의약품 제조업 | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | 프레스티지바이오파마 | Department | 경영지원실 |
| Position | General Manager | Phone Number | 051-58** |
| Name | 김민주 | Fax number | 051-20** |
| Email address | **[email protected] |
(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)
| Legal form | Co., Ltd. |
| Total Assets (or Total Assets Under Management) | 478,545,810 | Total Liabilities | 151,334,608 |
| Total Equity | 327,211,202 | Paid-in Capital | 525,727,248 |
| Representative (representative or managing partner) | 박소연 |
| Decision-Making Body (Decision Maker) | 이사회, 주주총회 |
| Largest Shareholder (Largest Investor) | Mayson Partners Pte.Ltd | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 21.65 |
주) 프레스티지바이오파마의 결산기는 6월이며, 상기 재무정보는 2026-06-30 연결 재무제표 기준입니다. 【 보고자의 최대주주가 법인, 기타단체, 법령상조합, 민법상 조합의 경우】* 법인명 : Mayson Parters Pte. Ltd
| Legal form | 유한회사(해외 투자목적회사) |
| Total Assets (or Total Assets Under Management) | 78,553,113 | Total Liabilities | 7,595,451 |
| Total Equity | 70,939,662 | Paid-in Capital | 100 |
| Representative (representative or managing partner) | 박소연 |
| Decision-Making Body (Decision Maker) | 이사회, 주주총회 |
| Largest Shareholder (Largest Investor) | 박소연 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 50 |
주) Mayson Partners Pte. Ltd의 결산기는 6월이며, 상기 재무정보는 2026-06-30 기준입니다.
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | 박소연 | Individual (Domestic) | CEO | 630115 | Republic of Korea | 부산광역시 강서구 명지2동 | Executive | Officers of affiliates, etc. |
| 2 | 김진우 | 개인(외국) | Executive | 640608 | United States | 서울특별시 서초구 반포대로 | Executive | Officers of affiliates, etc. |
| 3 | 임영수 | Individual (Domestic) | Officer of Affiliate | 630315 | Republic of Korea | 서울특별시 동작구 흑석동 | Officer of Issuer | Executive officers (registered) |
| 4 | 동현철 | Individual (Domestic) | Other | 610529 | Republic of Korea | 서울특별시 용산구 이촌동 | - | - |
| 5 | 박천수 | Individual (Domestic) | Other | 690912 | Republic of Korea | 서울특별시 강남구 도곡동 | - | - |
| * Address to town/district level only |
(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)
| Legal form | - |
| Total Assets (or Total Assets Under Management) | - | Total Liabilities | - |
| Total Equity | - | Paid-in Capital | - |
| Representative (representative or managing partner) | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Largest Investor) | - | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | - |
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
(2) Collective investment manager details
| Legal form | - |
| Paid-in Capital | - | Total Assets Under Management | - |
| Representative | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Corporate Representative) | - | Largest Shareholder Stake | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | 2026-07-10 | 프레스티지바이오파마 | 5 | 46,936,099 | 60.37 | 46,936,099 | 60.37 | 77,752,637 |
| This Report | 2026-11-09 | 프레스티지바이오파마 | 3 | 46,901,699 | 60.32 | 46,901,699 | 60.32 | 77,752,637 |
| Change | -34,400 | -0.05 | -34,400 | -0.05 | 0 |
4. Purpose of holding
| Impact on management control |
| Ⅰ. 이사 및 감사의 선임ㆍ해임 또는 직무의 정지Ⅱ. 이사 및 이사회 등 회사의 기관과 관련된 정관의 변경Ⅲ. 회사의 자본금의 변경Ⅳ. 회사의 배당 결정에 대한 영향Ⅴ. 회사의 합병(간이합병 및 소규모합병을 포함한다) 및 분할Ⅵ. 주식의 포괄적 교환 및 이전Ⅶ. 영업의 전부 또는 중요한 일부의 양수 또는 양도Ⅷ. 자산의 전부 또는 중요한 일부의 처분 또는 양도Ⅸ. 영업의 전부 또는 중요한 일부의 임대, 경영 위임 또는 타인과 영업의 손익 전부를 같이 하는 계약 기타 이에 준하는 계약의 체결, 변경 또는 해약Ⅹ. 회사의 해산보고자는 상위 Ⅰ∼Ⅹ 각 호 사항에 대하여 회사의 최대주주로서 회사에 영향력을 행사 할 수도 있습니다. 현재 Ⅰ∼Ⅹ 각 호의 사항에 대한 구체적인 계획은 없지만, 회사의 업무집행과 관련한 상위 사항이 발생할 경우에는 회사의 경영목적에 부합하도록 관련 행위들을 결정할 예정입니다. |
5. Reason for change
| Method of change | 장내매수 / 장외매수 |
| Reason for change | 특별관계자 장내매수 및 장외매수에 따른 보유주식수 변동 |
| Reason for Change | - |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | 프레스티지바이오파마 | 49190 | 31,122,728 | - | - | - | - | - | - | - | - | 31,122,728 | 40.03 |
| Specially Related Party | 박소연 | 630115 | 7,807,821 | - | - | - | - | - | - | - | - | 7,807,821 | 10.04 |
| 김진우 | 640608 | 7,815,201 | - | - | - | - | - | - | - | - | 7,815,201 | 10.05 |
| 임영수 | 630315 | 155,949 | - | - | - | - | - | - | - | - | 155,949 | 0.20 |
| 동현철 | 610529 | - | - | - | - | - | - | - | - | - | - | - |
| 박천수 | 690912 | - | - | - | - | - | - | - | - | - | - | - |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 77,752,637 | - | 60.32 | 60.32 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | 프레스티지바이오파마 | 49190 | 31,122,728 | - | - | - | - | - | - | 31,122,728 | 40.03 |
| Specially Related Party | 박소연 | 630115 | 7,807,821 | - | - | - | - | - | - | 7,807,821 | 10.04 |
| 김진우 | 640608 | 7,815,201 | - | - | - | - | - | - | 7,815,201 | 10.05 |
| 임영수 | 630315 | 155,949 | - | - | - | - | - | - | 155,949 | 0.20 |
| 동현철 | 610529 | - | - | - | - | - | - | - | - | - |
| 박천수 | 690912 | - | - | - | - | - | - | - | - | - |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| None |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| - | - | - | - | - | - | - | - | - | - | - | - |
| Total (number of shares, etc.) | - | Total (ratio) | - | - |
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| - | - | - | - | - | - | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | 프레스티지바이오파마 | 49190 | - | - | - | - | - | - | - | - | - | - | - |
| Specially Related Party | 박소연 | 630115 | - | - | - | - | - | - | - | - | - | - | - |
| 김진우 | 640608 | - | - | - | - | - | - | - | - | - | - | - |
| 임영수 | 630315 | 137,500 | - | - | - | - | - | - | - | - | 137,500 | 0.17 |
| 동현철 | 610529 | -80,000 | - | - | - | - | - | - | - | - | -80,000 | -0.10 |
| 박천수 | 690912 | -91,900 | - | - | - | - | - | - | - | - | -91,900 | -0.12 |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| 동현철 | 610529 | 2026.11.02 | 임원퇴임(-) | Voting Shares | 80,000 | -80,000 | 0 | - | - | - |
| 박천수 | 690912 | 2026.11.02 | 임원퇴임(-) | Voting Shares | 91,900 | -91,900 | 0 | - | - | - |
| 임영수 | 630315 | 2026.11.02 | On-Market Purchase (+) | Voting Shares | 18,449 | 29,000 | 47,449 | 1,131 | - | - |
| 임영수 | 630315 | 2026.11.03 | On-Market Purchase (+) | Voting Shares | 47,449 | 39,000 | 86,449 | 1,150 | - | - |
| 임영수 | 630315 | 2026.11.04 | 장외매수(+) | Voting Shares | 86,449 | 55,000 | 141,449 | 1,179 | - | 동현철 |
| 임영수 | 630315 | 2026.11.04 | On-Market Purchase (+) | Voting Shares | 141,449 | 3,000 | 144,449 | 1,168 | - | - |
| 임영수 | 630315 | 2026.11.05 | On-Market Purchase (+) | Voting Shares | 144,449 | 11,500 | 155,949 | 1,161 | - | - |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| 임영수 | 630315 | 159,349,500 | - | - | 159,349,500 |
(2) Origin and source of acquisition funds
ㅇ If own funds
| Name | Date of birth or business registration no., etc. | Source and Formation of Acquisition Funds |
| 임영수 | 630315 | Own Funds |